Table 3 Prevalence of anaemia as affected by sociodemographic and clinical factors in HIV positive and HIV negative participants
Categories | HIV Positive | HIV Negative | Overall | ||||||
|---|---|---|---|---|---|---|---|---|---|
n | Anaemia prevalence (n) | χ2 P | n | Anaemia prevalence (n) | χ2 P | N | Anaemia prevalence (n) | χ2 P | |
Gender | |||||||||
 Female | 238 | 64.7(154) | 31.9 | 61 | 49.2(30) | 5.16 | 299 | 61.5(184) | 39.4 |
 Male | 71 | 26.8(19) | 0.001* | 41 | 26.8(11) | 0.02* | 112 | 26.8(3 + 0) | < 0.001* |
Age group (years) | |||||||||
  ≤ 25 | 11 | 54.5(6) | 1.15 | 48 | 52.1(25) | 5.37 | 59 | 52.5(31) | 0.34 |
 26–40 | 156 | 59.0(92) | 0.56 | 35 | 28.6(10) | 0.07 | 191 | 53.4(102) | 0.84 |
  > 40 | 142 | 52.8(75) |  | 19 | 31.6(6) |  | 161 | 50.3(81) |  |
Malaria status | |||||||||
 Malaria positive | 24 | 79.2(19) | 5.67 | 34 | 47.1(16) | 0.99 | 58 | 60.3(35) | 1.85 |
 Malaria negative | 285 | 54.0(154) | 0.01 | 68 | 36.9(25) | 0.22 | 353 | 50.7(79) | 0.11 |
Fever status | |||||||||
 Febrile | 16 | 56.2(9) | 0.001 | 18 | 55.6(10) | χ2 = 2.14 | 34 | 55.9(19) | 0.21 |
 Afebrile | 293 | 56.0(164) | 0.50 | 84 | 36.9(31) | P = 0.11 | 377 | 51.7(195) | 0.38 |
ARV use | |||||||||
 Yes | 292 | 55.5(162) | 0.55 |  |  |  | 292 | 55.5(162) | 0.55 |
 No | 17 | 64.7(11) | 0.31 |  |  |  | 17 | 64.7(11) | 0.31 |
Duration on ARV | |||||||||
  < 12 months | 33 | 63.6(21) | 0.86 |  |  |  | 33 | 63.6(21) | 0.86 |
 12–35 months | 82 | 56.1(46) | 0.42 |  |  |  | 82 | 56.1(46) | 0.42 |
  ≥ 36 months | 191 | 55.0(105) |  |  |  |  | 191 | 55.0(105) |  |
CD4T-cell (cells/μl) | |||||||||
  < 200 | 41 | 73.2(30) | 3.78 |  |  |  | 41 | 73.2(30) | 3.78 |
 200–499 | 71 | 60.6(43) | 0.05 |  |  |  | 71 | 60.6(43) | 0.05 |
  ≥ 500 | 61 | 54.1(33) |  |  |  |  | 61 | 54.1(33) |  |